2024    2023    2022    2021    2020    2019    2018    2017    2016   

2023

Articles

71 - 

Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis

Alexandra Garcia, Emilie Dugast, Sita Shah, Jérémy Morille, Christine Lebrun-Frenay et al.

Neurology Neuroimmunology & Neuroinflammation, 2023, 10 (3), pp.e200091.

DOI : https://doi.org/10.1212/NXI.0000000000200091

Pubmed : 36810163

 

72 - 

Re-188-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)

Etienne Garin, Xavier Palard-Novello, Yan Rolland, Samuel Le Sourd, Nicolas Lepareur et al.

Cancers, 2023, 15 (8), pp.2245.

DOI : https://doi.org/10.3390/cancers15082245

Pubmed : 37190173

 

73 - 

Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study

Nathalie Gault, Delphine Bachelet, Cédric Laouénan, Raphaël Borie, Claire Cracowski et al.

Journal of Medical Virology, 2023, 95 (6), pp.e28819.

DOI : https://doi.org/10.1002/jmv.28819

Pubmed : 37246784

 

74 - 

Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference

Antoine Gavoille, Fabien Rollot, Romain Casey, Marc Debouverie, Emmanuelle Le Page et al.

Neurology, 2023, 100 (12), pp.e1296-e1308.

DOI : https://doi.org/10.1212/WNL.0000000000206774

Pubmed : 36564207

 

75 - 

Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort

Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy et al.

Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13.

DOI : https://doi.org/10.1016/j.cmi.2022.08.028

Pubmed : 36191847

 

76 - 

The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020

Viktoria Gloy, Andreas M Schmitt, Pascal Düblin, Julian Hirt, Cathrin Axfors et al.

International Journal of Cancer, 2023, 152 (12), pp.2474-2484.

DOI : https://doi.org/10.1002/ijc.34473

Pubmed : 36779785

 

77 - 

First Experience of Optimization of Tacrolimus Therapeutic Drug Monitoring in a Patient Cotreated With Nirmatrelvir/Ritonavir: How Microsampling Approach Changes Everything

Léonard Golbin, Camille Tron, Benedicte Franck, Cécile Vigneau, M Verdier et al.

Transplantation, 2023, 107 (2), pp.e68-e69.

DOI : https://doi.org/10.1097/TP.0000000000004430

Pubmed : 36696522

 

78 - 

Changes in French family medicine residents’ perspectives about patient partners’ participation in teaching: A qualitative study in co-facilitated practice exchange groups

Juliette Guary, P Hebert, Arnaud Maury, Maud Le Ridant, Pierric Renaut et al.

Medical Teacher, 2023, 45 (11), pp.1239-1246.

DOI : https://doi.org/10.1080/0142159X.2023.2200894

Pubmed : 37075245

 

79 - 

Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study

Lucas Guillo, Benoit Flachaire, Jérôme Avouac, Catherine Dong, Maria Nachury et al.

Digestive and Liver Disease, 2023, 55 (1), pp.61-68.

DOI : https://doi.org/10.1016/j.dld.2022.07.012

Pubmed : 35985961

 

80 - 

Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study

Pauline Guillot, Flora Delamaire, Arnaud Gacouin, Benoit Painvin, Caroline Piau et al.

BMC Infectious Diseases, 2023, 23 (1), pp.611.

DOI : https://doi.org/10.1186/s12879-023-08493-5

Pubmed : 37723456